Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014999 |
| CAS No | NA |
| Mol.F. | C15H17N5O4 |
| Mol.Wt. | 331.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141000 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O6S |
| Mol.Wt. | 567.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141001 |
| CAS No | NA |
| Mol.F. | C26H31F2N7O5S |
| Mol.Wt. | 591.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141002 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141003 |
| CAS No | NA |
| Mol.F. | C23H28FN7O5S |
| Mol.Wt. | 533.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141004 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141005 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141006 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141007 |
| CAS No | NA |
| Mol.F. | C25H29F2N7O6S |
| Mol.Wt. | 593.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141008 |
| CAS No | NA |
| Mol.F. | C14H22ClN5O5S |
| Mol.Wt. | 407.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141009 |
| CAS No | NA |
| Mol.F. | C21H23F2N7O4S |
| Mol.Wt. | 507.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141010 |
| CAS No | NA |
| Mol.F. | C14H22ClN5O6S |
| Mol.Wt. | 423.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141011 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141012 |
| CAS No | NA |
| Mol.F. | C15H22ClN5O6S |
| Mol.Wt. | 435.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141013 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141014 |
| CAS No | NA |
| Mol.F. | C21H33N7O9S |
| Mol.Wt. | 559.6 |
| INV STATUS | CUSTOM SYNTHESIS |